Resources Research Supplements

History of Cancer

Cancer has shaped human history for millennia, from ancient civilizations recognizing its presence to modern breakthroughs transforming treatment and survival. This timeline traces cancer’s journey from the earliest medical records through major discoveries, technological innovations, and paradigm shifts in our understanding. Each milestone represents not just a scientific achievement, but the collective human effort to understand and overcome one of our most persistent health challenges—and the remarkable progress in prevention, diagnosis, and treatment that brings hope to millions today.

For more information, visit: 

1
BCE - 18th Century

70 – 80 million years ago

Evidence of cancer cells in dinosaur fossils, found in 2003.

4.2 – 3.9 million years ago

The oldest known hominid malignant tumor was found in Homo erectus, or Australopithecus, by Louis Leakey in 1932.

3000 BCE

Egypt
Evidence of cancerous cells found in mummies.

1900–1600 BCE

Cancer found in remains of Bronze Age human female skull.

1750 BCE

Babylonian code of Hammurabi set a standard fee for surgical removal of tumors (ten shekels) and penalties for failure.

1600 BCE

Egypt
The Egyptians blamed cancer on the gods. Ancient Egyptian scrolls describe eight cases of breast tumors treated by cauterization.
Stomach cancer treated with boiled barley mixed with dates; cancer of the uterus by a concoction of fresh dates mixed with pig’s brain introduced into the vagina.

1100–400 BCE

China
Physicians specializing in treating swellings and ulcerations were referred to in The Rites of the Zhou Dynasty.

500 BCE

India
Indian epic tale, the Ramayana, described treatment with arsenic paste to thwart tumor growth.

400 BCE

Peru
Pre-Colombian Inca mummies found to contain lesions suggestive of malignant melanoma.

400 BCE

Greece
Greek physician Hippocrates (460–370 BCE), the “Father of Medicine,” believed illness was caused by an imbalance of four bodily humors: yellow bile, black bile, blood, and phlegm. He was the first to recognize differences between benign and malignant tumors.

Circa 250 BCE

China
The first clinical picture of breast cancer, including progression, metastatis, and death, and prognosis approximately ten years after diagnosis, was described in The Nei Ching, or The Yellow Emperor’s Classic of Internal Medicine. It gave the first description of tumors and five forms of therapy: spiritual, pharmacological, diet, acupuncture, and treatment of respiratory diseases.

50 AD

Italy
The Romans found some tumors could be removed by surgery and cauterized, but thought medicine did not work. They noted some tumors grew again.

100 AD

Italy
Greek doctor Claudius Galen (129–216 AD) removed some tumors surgically, but he generally believed that cancer was best left untreated. Galen believed melancholia the chief factor in causing breast cancer, and recommended special diets, exorcism, and topical applications.

500–1500

Europe
Surgery and cautery were used on smaller tumors. Caustic pastes, usually containing arsenic, were used on more extensive cancers, as well as phlebotomy (blood-letting), diet, herbal medicines, powder of crab, and symbolic charms.

1400–1500s

Italy
Leonardo da Vinci (1452–1519) dissected cadavers for artistic and scientific purposes, adding to the knowledge of the human body.

1492

Christopher Columbus returned to Europe from the Americas with the first tobacco leaves and seeds ever seen on the continent. A crew member, Rodrigo de Jerez, was seen smoking and imprisoned by the Inquisition, which believed he was possessed by the devil.

1500

Europe
Autopsies were conducted more often and understanding of internal cancers grew.

1595

Netherlands
Zacharias Janssen invented the first compound microscope.

17th century

Netherlands
Dutch surgeon Adrian Helvetius performed both lumpectomy and mastectomy, claiming this cured breast cancer.

17th century

Germany
Cancer surgery techniques improved, but lack of anesthesia and antiseptic conditions made surgery a risky choice. German surgeon Wilhelm Fabricius Hildanus (1560–1634) removed enlarged lymph nodes in breast cancer operations, while Johann Scultetus (1595–1645) performed total mastectomies.

17th century

France
Physician Claude Gendron (1663–1750) concluded that cancer arises locally as a hard, growing mass, untreatable with drugs, and that it must be removed with all its “filaments.”

17th century

Germany
Professor Hermann Boerhaave (1668–1738) believed inflammation could result in cancer.

17th–18th centuries

Netherlands
Antony van Leeuwenhoek (1632–1723) refined the single lens microscope and was the first to see blood cells and bacteria, aiding the better understanding of cells, blood, and lymphatic system— major steps in improving the understanding of cancer.

France
Physician Le Dran (1685–1770) first recognized that breast cancer could spread to the regional auxiliary lymph nodes, carrying a poorer prognosis.

1713

Italy
Dr. Bernardino Ramazzini (1633–1714), a founder of occupational/industrial medicine, reported the virtual absence of cervical cancer and relatively high incidence of breast cancer in nuns. This observation was an important step toward identifying hormonal factors such as pregnancy and infections related to sexual contact in cancer risk, and was the first indication that lifestyle might affect the development of cancer.

1733–88

France
Physicians and scientists performed systematic experiments on cancer, leading to oncology as a medical specialty. Two French scientists— physician Jean Astruc and chemist Bernard Peyrilhe— were key to these new investigations.

1761

Padua, Italy
Giovanni Morgagni performed the first autopsies to relate the patient’s illness to the science of disease, laying the foundation for modern pathology.

1761

UK
Dr. John Hill published “Cautions Against the Immoderate Use of Snuff,” the first report linking tobacco and cancer.

1775

UK
Dr. Percival Pott of Saint Bartholomew’s Hospital in London described cancer in chimney sweeps caused by soot collecting under their scrotum, the first indication that exposure to chemicals in the environment could cause cancer. This research led to many additional studies that identified other occupational carcinogens and thence to public health measures to reduce cancer risk.

1779

France
First cancer hospital founded in Reims. It was forced to move from the city because people believed cancer was contagious.

18th century

Scotland
Scottish surgeon John Hunter (1728–93) stated that tumors originated in the lymph system and then seeded around the body. He suggested that some cancers might be cured by surgery, especially those that had not invaded nearby tissue.


2
19th Century

19th century

Scotland
In the early 1800s, Scottish physician John Waldrop proposed that “glioma of the retina,” which typically appeared within the eyes of newborns and young children and was usually lethal, might be cured via early removal of affected organs.

1829

France
Gynecologist Joseph Recamier described the invasion of the bloodstream by cancer cells, coining the term metastatis, which came to mean the distant spread of cancer from its primary site to other places in the body.

1838

Germany
Pathologist Johannes Müller demonstrated that cancer is made up of cells and not lymph. His student, Rudolph Virchow (1821–1902), later proposed that chronic inflammation— the site of a wound that never heals— was the cause of cancer.

1842

Italy
Domenico Antonio Rigoni-Stern undertook first major statistical analysis of cancer incidence and mortality using 1760–1839 data from Verona. This showed that more women than men died from tumors, and that the commonest female cancers were breast and uterine (each accounting for a third of total deaths). He found cancer death rates for both sexes were rising and concluded that incidence of cancer increases with age, that cancer is found less in the country than in the city, and that unmarried people are more likely to contract the disease.

1845

Scotland
John Hughes Bennett, the Edinburgh physician, was the first to describe leukemia as an excessive proliferation of blood cells.

1851–1971

UK
Decennial reports linked cancer death to occupation and social class.

1880

Earlier invention of general anesthesia (chloroform, ether, nitrous oxide) became more widespread, making cancer surgery more acceptable.

1881

USA
First practical cigarette-making machine patented by James Bonsack. It could produce 120,000 cigarettes a day, each machine doing the work of 48 people. Production costs plummeted, and— with the invention of the safety match a few decades later— cigarette smoking began its explosive growth.

1886

Brazil
Hereditary basis for cancer first suggested after Professor Hilario de Gouvea of the Medical School in Rio de Janeiro reported a family with increased susceptibility to retinoblastoma.

1890s

USA
Professor William Stewart Halsted at Johns Hopkins University developed the radical mastectomy for breast cancer, removing breast, underlying muscles, and lymph nodes under the arm.

1895

Germany
Physicist Wilhelm Konrad Roentgen (1845–1923) discovered X-rays, used in the diagnosis of cancer. Within a few years, this led to the use of radiation for cancer treatment.

1897

USA
Walter B. Cannon (1871–1945) was still a college student when he fed bismuth and barium mixtures to geese, outlining their gullets on an X-ray plate (the forerunner of the Barium meal examination).

19th century

Invention and use of the modern microscope, which later helped identify cancer cells.

19th century

Germany
Johannes Müller’s student Rudolph Virchow (1821–1902), “the founder of cellular pathology”, determined that all cells, including cancer cells, are derived from other cells. He was the first to coin the term “leukemia” and believed that chronic inflammation was the cause of cancer.

19th century

Germany
Surgeon Karl Thiersch showed cancers metastasize through the spread of malignant cells.

1800s

UK
Surgeon Stephen Paget (1855–1926) first deduced that cancer cells spread to all organs of the body by the bloodstream, but only grow in the organ (“soil”) they find compatible. This laid the groundwork for the true understanding of metastasis.

1895

Scotland
Dr. Thomas Beatson discovered that the breasts of rabbits stopped producing milk after he removed the ovaries. This control of one organ over another led Beatson to test what would happen if the ovaries were removed in patients suffering from advanced breast cancer, and the found that oophorectomy often resulted in improvement. He thus discovered the stimulating effect of estrogen on breast tumors long before the hormone was discovered. This work provided a foundation for the modern use of hormones and analogs (e.g. tamoxifen, taxol) for treatment and prevention of breast cancer.


3
20th Century

Before 1900

Lung cancer was extremely rare; now it is one of the most common cancers.

By 1900

Hundreds of materials, both man-made and natural, were recognized as causes of cancer (carcinogens).

1902

X-ray exposure led to skin cancer on the hand of a lab technician. Within a decade, many more physicians and scientists, unaware of the dangers of radiation, developed a variety of cancers.

1905

UK
Physicians at the Royal Ophthalmology Hospital reported the first case of “hereditary” retinal glioma, which presented in the child of a parent cured of the disease.

1907

USA
Epidemiological study found that meat-eating Germans, Irish, and Scandinavians living in Chicago had higher rates of cancer than did Italians and Chinese, who ate considerably less meat.

1910

Austria
First national cancer society founded: Austrian Cancer Society.

1911

France
Marie Curie was awarded a second Nobel Prize, this time in chemistry, in recognition of her work in radioactivity.

1900–1950

Radiotherapy— the use of radiation to kill cancer cells or stop them dividing— was developed as a treatment.

1911

USA
Peyton Rous (1879–1970) proved that viruses caused cancer in chickens, for which he was eventually awarded the Nobel Prize in 1966.

1913

USA
The American Cancer Society was founded as the American Society for the Control of Cancer (ASCC) by 15 physicians and business leaders in New York City. In 1945, the ASCC was renamed the American Cancer Society. It remains the world’s largest voluntary organization.

1915

Japan
Cancer was induced in laboratory animals for the first time by a chemical, coal tar, applied to rabbits’ skin at Tokyo University. Soon many other substances were observed to be carcinogens, including benzene, hydrocarbons, aniline, asbestos, and tobacco.

1926

England
Physician and epidemiologist Janet Lane-Claypon (1877–1967) published results from a study that demonstrated some of the major contemporary risk factors for breast cancer among women, including not breastfeeding, being childless, and older age at first pregnancy.

1928

Greece
George Papanicolaou (1883–1962) identified malignant cells among the normal cast off vaginal cells of women with cancer of the cervix, which led to the Pap smear test.

1930

Germany
Researchers in Cologne drew the first statistical connection between smoking and cancer.

1930s

Puerto Rico
Dr. Cornelius Rhoads, a pathologist, allegedly injected his Puerto Rican subjects with cancer cells— 13 people died.

1933

The Union for International Cancer Control (UICC) founded.

1933

Spain
First World Cancer Congress held in Madrid.

1930s–1950s

Classification of breast cancer introduced, enabling the planning of more rational treatment tailored to the individual.

1934

UK
Drs. W. Burton Wood and S. R. Gloyne reported the first two cases of lung cancer linked to asbestos.

1937

USA
National Cancer Institute inaugurated.

1939

USA
Drs. Alton Ochsner and Michael DeBakey first reported the association of smoking and lung cancer.

1939–45

During the Second World War, the US Army discovered that nitrogen mustard was effective in treating cancer of the lymph nodes (lymphoma). This was the birth of chemotherapy— the use of drugs to treat cancer.

1943–45

Denmark, UK
First national cancer registries established.

1947

Canada
Dr. Norman Delarue compared 50 patients with lung cancer with 50 patients hospitalized with other diseases. He discovered that over 90% of the first group— but only half of the second— were smokers, and confidently predicted that by 1950 no one would be smoking.

1947

USA
Sidney Farber (1903–73), one of the founders of the specialty of pediatric pathology, used a derivative of folic acid, methotrexate, to inhibit acute leukemia in children.

1940s–1950s

USA
Dr. Charles B. Huggins’ (1901–97) research on prostate cancer changed the way scientists regard the behavior of all cancer cells, and for the first time brought hope to the prospect of treating advanced cancers. He showed that cancer cells were not autonomous and self-perpetuating but were dependent on chemical signals such as hormones to grow and survive, and that depriving cancer cells of these signals could restore the health of patients with widespread metastases. He was awarded the Nobel Prize in 1966 (shared with Peyton Rous).

1950

USA
Gertrude Elion (1918–99) created a purine chemical, which she developed into 6-mercaptopurine, or 6-MP. It was rapidly approved for use in childhood leukemia. She received the Nobel Prize in 1988.

1950

USA
The link between smoking and lung cancer was confirmed. A landmark article from The Journal of the American Medical Association appeared on May 27th, 1950: “Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma” by E.L. Wynder and Evarts Graham. The same issue featured a full-page ad for Chesterfields with the actress Gene Tierney and golfer Ben Hogan; the journal accepted tobacco ads until 1953.

1951

UK
Dr. Richard Doll and Prof. Austin Bradford Hill conducted the first large-scale study of the link between smoking and lung cancer.

1953

UK
James Watson and Francis Crick described the double helical structure of DNA, marking the beginning of the modern era of genetics.

1954

USA
First tobacco litigation against the cigarette companies, brought by a widow on behalf of her smoker husband, who died from cancer. The cigarette companies won.

1956

USA
Dr. Min Chiu Li ( –1980) first demonstrated clinically that chemotherapy could result in the cure of a widely metastatic malignant disease.

1960

Japan
Group cancer screening for stomach cancer began with a mobile clinic in Tohoku region.

1960

USA
Dr. Min Chiu Li published another important and original finding: the use of multiple-agent combination chemotherapy for the treatment of metastatic cancers of the testis. Twenty years later, it was demonstrated that combination chemotherapy, combined with techniques for local control, had virtually eliminated deaths from testicular malignancy.

1963

Japan
Cancer research programs were established by the Ministry of Health and Welfare and the Ministry of Education, Science, and Culture.

1964

USA
Physician Irving J. Selikoff (1915-1992) published the results from a study linking asbestos exposure to the development of mesothelioma.

1964

USA
First US Surgeon General’s report on smoking and health.

1965

WHO established International Agency for Research on Cancer (IARC), based in Lyon, France.

1966

International Association of Cancer Registries (IACR) founded.

1960s–1970s

Trials in several countries demonstrated the effectiveness of mammography screening for breast cancer.

1970s

USA, Italy
Bernard Fisher in the USA and Umberto Veronesi in Italy both launched long-term studies as to whether lumpectomy followed by radiation therapy was an option to radical mastectomy in early breast cancer. These studies concluded that total mastectomy offered no advantage over either lumpectomy or lumpectomy plus radiation therapy.

1971

USA
The National Cancer Act in President Nixon’s “War on Cancer” mandated financial support for cancer research, established a network of population-based cancer registries, outlined intervention strategies, and, in 1973, established the Surveillance, Epidemiology, and End Results (SEER) program.

1973

USA
Bone marrow transplantation first performed successfully on a dog in Seattle by Dr. E. Donnall Thomas (1920– ). This led to human bone marrow transplantation, resulting in cures for leukemias and lymphomas. In 1990, Dr. Thomas won a Nobel Prize for his work.

1970s

Childhood leukemia became one of the first cancers that could be cured by a combination of drugs.

1970s

USA
Discovery of the first cancer gene (the oncogene, which in certain circumstances can transform a cell into a tumor cell).

1970s onwards

WHO, UICC, and others promoted national cancer planning for nations to prioritize and focus their cancer activities.

1981

Japan
Professor Takeshi Hirayama (1923–95) published the first report linking passive smoking and lung cancer in the non-smoking wives of men who smoked.

1981

Italy
Dr. G. Bonnadona in Milan performed the first study of adjuvant chemotherapy for breast cancer using cyclophosphamide, methotrexate, and 5-fluorouracil, resulting in reduction of cancer relapse. Adjuvant chemotherapy is now standard treatment for lung, breast, colon, stomach, and ovary cancers.

1980s

USA
Kaposi’s sarcoma and T-cell lymphoma linked to AIDS.

1982

USA
Nobel Laureate Baruch S. Blumberg was instrumental in developing a reliable and safe vaccine against hepatitis B (which causes primary liver cancer).

1980s

Australia
Barry Marshall and J. Robin Warren identified bacterium H. pylori, noting it caused duodenal and gastric ulcers and increased the risk of gastric cancer.

1980s

USA
Vincent DeVita developed a four-drug combination to significantly raise the cure rate of Hodgkin’s disease to 80%.

Mid-1980s

Human Genome Project was initiated to pinpoint the location and function of an estimated 50,000–100,000 genes that make up the inherited set of “instructions” for functions and behavior of human beings.

1980s

WHO Program on Cancer Control established.

1988

Global First WHO World No Tobacco Day, subsequently an annual event.

1989

European Network of Cancer Registries (ENCR) established.

1989

USA
National Institutes of Health researchers performed the first approved gene therapy, inserting foreign genes to track tumor-killing cells in cancer patients. This project proved the safety of gene therapy.

1991

Evidence linking specific environmental carcinogens to telltale DNA damage emerged, e.g. sub radiation was found to produce change in tumor suppressor genes in skin cells, aflatoxin (a fungus poison) or hepatitis B virus to cause a mutation in the liver, and chemicals in cigarette smoke to switch on a gene that makes lung cells vulnerable to the chemicals’ cancer-causing properties.

1994

USA, Canada, UK, France, Japan
Scientists collaborated and discovered BRCA1, the first breast and ovarian cancer predisposing gene.

1994

USA
National Program of Cancer Registries (NPCR) established.

1995

Gene therapy, immune system modulation, and genetically engineered antibodies used to treat cancer.

1999

Netherlands, USA
Jan Walboomers of the Free University of Amsterdam and Michele Manos of Johns Hopkins provided evidence that the human papillomavirus is present in 99.7% of all cases of cervical cancer.

1999

The Bill & Melinda Gates Foundation awarded a five-year, $50 million grant to the Alliance for Cervical Cancer Prevention (ACCP), a group of five international organizations with a shared goal of working to prevent cervical cancer in developing countries.


4
21st century

2000

53rd World Health Assembly presided over by Dr. Libertina Amathila (Namibia) endorsed “Global strategy for non-communicable disease (NCD) prevention and control,” which outlined major objectives for monitoring, preventing, and managing NCDs, with special emphasis on major NCDs with common risk factors and determinants— cardiovascular disease, cancer, diabetes, and chronic respiratory disease.

2000

The entire human genome is mapped.

2000

Charter of Paris Against Cancer is signed.

2001

Luxembourg
International Childhood Cancer Day was launched, its aim to raise awareness of the 250,000 children worldwide who get cancer every year. Some 80% of these children have little or no access to treatment. The first annual event in 2002 was supported in 30 countries around the world and raised over US$100,000 for parent organizations to help children in their own countries.

2004

Geneva, Switzerland
WHO cancer prevention and control resolution approved by World Health Assembly.

2005

WHO Framework Convention on Tobacco Control came into force, using international law to further public health and prevent cancer.

2006

USA
The US Federal Drug Administration approved the first HPV vaccine to prevent infections that cause cervical cancer.

2011

The FDA approved immunotherapy (Ipilimumab, checkpoint blockade) to treat advanced metastatic melanoma.

2011

Lung cancer deaths reduced by low-dose computed tomography (CT) scanning of people at high risk.

2011

UN High Level Meeting on Non-communicable Diseases in New York, US.

2013

WHO launched the Global Action Plan for the Prevention and Control of NCDs (2013-2020), including strategies to reduce cancer incidence and mortality by promoting prevention and early detection.

2014

The International Cancer Control Partnership (ICCP) was co-convened by the NCI and WHO to support governments in developing and implementing evidence-based national cancer control plans​.

2015

WHO launched initiatives to introduce and expand HPV vaccination in low- and middle-income countries to reduce cervical cancer incidence.

2016

The US Congress passes the 21st Century Cures Act, which provides funding for the Cancer Moonshot, a broad program to accelerate cancer research by investing in specific research initiatives that have the potential to transform cancer care, detection, and prevention.

2017

USA
CAR T-cell therapies are approved by the US Food and Drug Administration (FDA) to treat some kinds of lymphomas and leukemias, as well as multiple myeloma.

2017

USA
The US FDA has extended approval of pembrolizumab for treating metastatic and inoperable solid tumors with certain genetic changes that have progressed following prior treatment and lack alternative options. This tissue-agnostic approval makes pembrolizumab the first cancer treatment based solely on a tumor’s genetic feature rather than cancer type.

2018

WHO issued a global call to eliminate cervical cancer as a public health problem, which led to the development of the Global Strategy in 2020. WHO signature initiatives on childhood cancer - to provide universal access to cancer diagnosis, treatment, and care for children by 2030 - and breast cancer - to strengthen health systems to save 2.5 million lives over two decades have been subsequently launched.

2018

USA
The US FDA approves larotrectinib, the first drug targeting tumors with NTRK gene fusions for pediatric or adult patients with metastatic or inoperable solid tumors that have progressed after prior treatment. Larotrectinib is the second drug approved for cancer treatment based on specific molecular features, regardless of tumor location.

2018

The American Cancer Society updated its colorectal cancer screening guidelines to lower the recommended starting age for average-risk adults from 50 to 45 years in response to the increase of young-onset colorectal cancer.

2020

The Pan-Cancer Analysis of Whole Genomes study, which used data collected by the International Cancer Genome Consortium and TCGA, uncovers the complex role that changes throughout the genome play in cancer development, growth, and spread.

2021

The FDA approved the immunotherapy drug atezolizumab (Tecentriq) as an additional, or adjuvant, treatment after surgery and chemotherapy for patients with Stage II-IIIA non-small cell lung cancer and whose tumor expressed PD-1.

2024

The NCI and WHO renewed their collaboration to enhance global cancer control efforts, focusing on governance, accountability, and cancer plan implementation research​.

2024

Trials began for personalized cancer vaccines using mRNA technology to reduce recurrence risk by training the immune system to target specific cancer cells, with expectations to complete by 2027.

2025

U.S. Surgeon General issued an advisory sharing how alcohol increases cancer risk, calling for a new health warning label on alcoholic beverages.